miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1

Huanxin Liu1,2, Xiaoxia Wu2, Jie Huang1

  • 1Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Insights

MicroRNA-7 (miR-7) plays a crucial role in small cell lung cancer (SCLC) chemoresistance by targeting the MRP1/ABCC1 gene. Low miR-7 levels correlate with poor drug response and survival in SCLC patients.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression in biological processes.
  • miR-7 exhibits context-dependent roles as a tumor suppressor or oncogene in human cancers.
  • Chemoresistance is a major challenge in treating small cell lung cancer (SCLC).

Purpose of the Study:

  • To investigate the functional role of miR-7 in SCLC chemoresistance.
  • To elucidate the underlying molecular mechanism involving miR-7 and its potential targets.
  • To assess miR-7 as a prognostic biomarker and therapeutic target in SCLC.

Main Methods:

  • Bioinformatic analysis to identify potential miR-7 targets.
  • Quantitative reverse transcription-polymerase chain reaction and immunohistochemistry to analyze miR-7 and MRP1/ABCC1 expression in SCLC samples.
  • Cell-based assays (transfection with miR-7 mimic/inhibitor) and dual-luciferase reporter assay to confirm gene targeting.

Main Results:

  • MRP1/ABCC1 was identified as a potential target of miR-7.
  • Low miR-7 expression was significantly associated with reduced drug responsiveness and overall survival in SCLC patients.
  • An inverse relationship between miR-7 and MRP1/ABCC1 expression was observed, with miR-7 repressing MRP1/ABCC1 levels.

Conclusions:

  • miR-7 mediates chemoresistance in SCLC by downregulating MRP1/ABCC1 expression.
  • miR-7 holds potential as a prognostic predictor for SCLC patients.
  • Targeting miR-7 represents a potential therapeutic strategy for overcoming chemoresistance in SCLC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
43